Skip to Main Content (Press Enter)

Logo UNICH
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNICH

|

UNI-FIND

unich.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

Anti-Cholinergic Derangement of Cortical Metabolism on 18F-FDG PET in a Patient with Frontotemporal Lobar Degeneration Dementia: A Case of the TREDEM Registry

Articolo
Data di Pubblicazione:
2020
Abstract:
We present the case of a patient with an atypical course of frontotemporal lobar degeneration (FTLD) complicated by the use of an anticholinergic drug. A 70-year-old patient, followed by psychiatrists for depression and behavioral disorders, received a diagnosis of dementia with Lewy bodies (DLB) at another Center due to auditory hallucinations, gait impairment, and tendency to fall. He was then admitted to our Memory Clinic Unit for behavioral disturbances, such as delusional thinking, auditory hallucinations, and memory complaints. At that time, the patient's therapy included Lorazepam, Quetiapine, Promazine, and Biperiden. The latter was immediately suspended for the absence of extrapyramidal signs and to avoid the anticholinergic cognitive side effects. A 18F-FDG PET showed a derangement of cortical metabolism with diffusely reduced activity, and limited areas of hyperactivity involving lateral frontal and lateral temporal inferior regions bilaterally. The patient underwent a series of exams, including neuropsychological tests, 123I-MIBG scintigraphy, cerebrospinal fluid examination, and genetic analysis. A second 18F-FDG PET showed an extensive remodulation of metabolic activity: relative higher concentration of the tracer in the prefrontal and inferior temporal cortex was no more detectable. Similarly, the diffuse reduced metabolic activity could not be traced anymore. Nonetheless, the metabolic activity still appeared reduced in the frontal lobe, in the anterior cingulate bilaterally, and in the anterior part of the hemispheric fissure. Taken together, clinical and neuroimaging features would point to a FTLD-like form. Furthermore, the diagnostic work-up was likely confounded by the anticholinergic drug on 18F-FDG PET, highlighting the importance of carefully checking the patient's pharmacology during the diagnostic process.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Anti-cholinergics; cerebral cortex; frontotemporal dementia; PET scan; TREDEM
Elenco autori:
Gallucci, M.; Pallucca, C.; DI Battista, M. E.; Bergamelli, C.; Fiore, V.; Boccaletto, F.; Fiorini, M.; Perra, D.; Zanusso, G.; Fenoglio, C.; Serpente, M.; Galimberti, D.; Bonanni, L.
Autori di Ateneo:
BONANNI Laura
Link alla scheda completa:
https://ricerca.unich.it/handle/11564/733930
Pubblicato in:
JOURNAL OF ALZHEIMER'S DISEASE
Journal
  • Dati Generali

Dati Generali

URL

https://content.iospress.com/articles/journal-of-alzheimers-disease/jad191290
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 25.6.1.0